Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Atg5 deficiency alters myofibroblast accumulation and alveolar regeneration in lung fibrosis.

Stem cell reports·2026
Same author

Bispecific antibody engineered extracellular vesicles redirect T cells to prevent postoperative epidural fibrosis.

Nature communications·2026
Same author

Dupilumab attenuate IL-4 and IL-13 synergistic effect on airway remodeling in asthma via blocking IL-4Rα/STAT6 axis.

Scientific reports·2026
Same author

Progenitor Resilience and the Early Onset of Chronic Lung Diseases: NHLBI workshop report.

American journal of respiratory cell and molecular biology·2026
Same author

Saving the lung from ozone pollutant: a new role of hyaluronan in alveolar regeneration.

American journal of respiratory cell and molecular biology·2026
Same author

Activation of the impaired NAMPT/SIRT7/SOD2 axis restores alveolar progenitor cell renewal in idiopathic pulmonary fibrosis.

The Journal of clinical investigation·2026

相关实验视频

Updated: Jul 17, 2026

Flow Cytometric Analysis for Identification of the Innate and Adaptive Immune Cells of Murine Lung
09:57

Flow Cytometric Analysis for Identification of the Innate and Adaptive Immune Cells of Murine Lung

Published on: November 16, 2021

通过 CD44 解决肺炎.

Priit Teder1, R William Vandivier, Dianhua Jiang

  • 1Department of Medicine, Pulmonary and Critical Care Section, Yale University School of Medicine, New Haven, CT 06520, USA.

Science (New York, N.Y.)
|April 6, 2002
PubMed
概括

细胞表面分子CD44对于解决肺炎至关重要. 缺乏CD44的小鼠由于持续的炎症和细胞碎片的清除不良,导致愈合受损.

科学领域:

  • 免疫学 免疫学 免疫学
  • 细胞生物学 细胞生物学
  • 肺部医学 肺部医学

背景情况:

  • 组织修复需要解决炎症和清除矩阵碎片.
  • 细胞表面分子在炎症解决中的作用是一个活跃的研究领域.

研究的目的:

  • 为了研究CD44 (一种氨酸受体) 在解决肺炎中的功能.
  • 为了确定CD44是否对于肺损伤后的有效组织修复至关重要.

主要方法:

  • 利用缺乏CD44的小鼠来模拟肺损伤.
  • 评估了炎症标志物,亡性中性粒细胞清除率和氨酸片段积累.
  • 用CD44阳性细胞进行细胞复合实验.

主要成果:

  • 缺少CD44的小鼠在受伤后表现出持续的肺炎.
  • 观察到亡性中性粒细胞的清除受损和持续的氨酸片段积累.
  • 在缺乏CD44的小鼠中,转化生长因子-β1的激活也减少了.

结论:

  • CD44在肺炎的解决过程中起着至关重要的作用.
  • 恢复CD44功能部分逆转了炎症表型,突出了其在组织修复机制中的重要性.

更多相关视频

Detection of CD40 Protein-Umbelliferone Interaction via Differential Scanning Fluorescence
05:30

Detection of CD40 Protein-Umbelliferone Interaction via Differential Scanning Fluorescence

Published on: March 1, 2024

相关实验视频

Last Updated: Jul 17, 2026

Flow Cytometric Analysis for Identification of the Innate and Adaptive Immune Cells of Murine Lung
09:57

Flow Cytometric Analysis for Identification of the Innate and Adaptive Immune Cells of Murine Lung

Published on: November 16, 2021

Detection of CD40 Protein-Umbelliferone Interaction via Differential Scanning Fluorescence
05:30

Detection of CD40 Protein-Umbelliferone Interaction via Differential Scanning Fluorescence

Published on: March 1, 2024